Table 2

Baseline characteristics of patients

Control treatment (n=37)UL training (n=33)LL training (n=31)
*Mean (SD); †median (IQR).
(0/1), binary scored;UL, upper limb; LL, lower limb; M/F, male/female; TACI, total anterior cerebral infarct; PACI, partial anterior cerebral infarct; LACI, lacunar infarct; MMSE, mini mental state examination; TFT, thumb finding test; OPS, Orpington prognostic scale.
Demography:
    M/F14/2316/1713/18
    Age (y)*64.1 (15.0)69.0 (9.8)64.5 (9.7)
Stroke characteristics:
    Left/right13/2416/1713/18
    TACI251917
    PACI91113
    LACI331
Clinical characteristics:
    Glasgow coma scale (0–15)†15 (15–15)15 (15–15)15 (15–15)
    MMSE (0–30)†26 (24–28)27 (24–29)27 (26–29)
    Urinary incontinence (0/1)19 (51%)19 (58%)11 (35%)
    Sitting balance (0/1)26 (70%)23 (70%)25 (81%)
    Visual gaze deficit (0/1)12 (32%)8 (24%)5 (16%)
    Hemianopia (0/1)15 (41%)11 (33%)7 (23%)
    Visual inattention (0/1)20 (54%)17 (51%)14 (45%)
    TFT score (0–3)†1 (0.5–2)1 (0–2)1 (0–2)
    OPS (1.6–6.8)†4.8 (4.0–5.0)4.4 (3.6–5.2)4.2 (3.6–4.8)
Social support14 (38%)15 (45%)11 (35%)
Outcome variables at baseline:
    ADL ability (BI)†5.5 (3–7)5 (3–7)6 (3–8)
    Walking ability (FAC)†0 (0–1)0 (0–1)1 (0–2)
    Dexterity (ARAT)†0 (0–0)0 (0–1)0 (0–6)
    Walking velocity (m/s)*0 (0)0 (0)0 (0)
    Frenchay activities index*26.8 (6.8)26.5 (6.1)27.1 (7.0)
    Nottingham health profile*16.5 (6.7)17.5 (9.3)14.5 (6.4)
    Sickness impact profile*41.2 (11.7)38.6 (10.9)42.5 (6.5)
Time from stroke onset to start of treatment (days)*7.5 (2.9)7.2 (2.8)7.0 (2.5)